Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liana S Rosenthal

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Continuum (Minneapolis, Minn.)|October 12, 2022
Neurodegenerative Cerebellar AtaxiaLiana S Rosenthal
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 12, 2025
Treatment of primary adult-onset neurodegenerative cerebellar ataxiasLeonardo E Ariello, David P W Rastall, Liana S Rosenthal
Lancet (London, England)|August 9, 2025
Vesicular monoamine transport inhibitors: current uses and future directionsLiana S Rosenthal, Mena Farag, N Ahmad Aziz, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|February 27, 2013
Dual treatment of hemichorea-hemiballismus syndrome with tetrabenazine and chemodenervationChizoba C Umeh, Paige Nichols, Liana S Rosenthal, et al.
Pharmacological Reviews|October 19, 2021
Parkinson Disease: Translating Insights from Molecular Mechanisms to NeuroprotectionSheila K Pirooznia, Liana S Rosenthal, Valina L Dawson, et al.
Cerebellum (London, England)|May 2, 2026
An International Survey of Patients with Ataxia: Trends in Patient-Reported SymptomsCeleste Suart, Aimee Alcott, Lori Shogren, et al.
Journal of the Neurological Sciences|April 9, 2021
Rating scales and biomarkers for CAG-repeat spinocerebellar ataxias: Implications for therapy developmentMeng-Ling Chen, Chih-Chun Lin, Liana S Rosenthal, et al.
Journal of Proteome Research|August 13, 2021
Evaluation of the Sensitivity and Reproducibility of Targeted Proteomic Analysis Using Data-Independent Acquisition for Serum and Cerebrospinal Fluid ProteinsKyung-Cho Cho, Sungtaek Oh, Yuefan Wang, et al.
Parkinsonism & Related Disorders|April 17, 2026
The relationship between level of education and disease onset and progression in spinocerebellar ataxia types 1, 2, 3, and 6Collin J Anderson, Daria Nesterovich Anderson, Ashley Kucharski, et al.
Clinical Proteomics|May 12, 2020
Development of a novel method for the quantification of tyrosine 39 phosphorylated α- and β-synuclein in human cerebrospinal fluidChan Hyun Na, Gajanan Sathe, Liana S Rosenthal, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Continuum (Minneapolis, Minn.)|October 12, 2022
Neurodegenerative Cerebellar AtaxiaLiana S Rosenthal
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 12, 2025
Treatment of primary adult-onset neurodegenerative cerebellar ataxiasLeonardo E Ariello, David P W Rastall, Liana S Rosenthal
Lancet (London, England)|August 9, 2025
Vesicular monoamine transport inhibitors: current uses and future directionsLiana S Rosenthal, Mena Farag, N Ahmad Aziz, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|February 27, 2013
Dual treatment of hemichorea-hemiballismus syndrome with tetrabenazine and chemodenervationChizoba C Umeh, Paige Nichols, Liana S Rosenthal, et al.
Pharmacological Reviews|October 19, 2021
Parkinson Disease: Translating Insights from Molecular Mechanisms to NeuroprotectionSheila K Pirooznia, Liana S Rosenthal, Valina L Dawson, et al.
Cerebellum (London, England)|May 2, 2026
An International Survey of Patients with Ataxia: Trends in Patient-Reported SymptomsCeleste Suart, Aimee Alcott, Lori Shogren, et al.
Journal of the Neurological Sciences|April 9, 2021
Rating scales and biomarkers for CAG-repeat spinocerebellar ataxias: Implications for therapy developmentMeng-Ling Chen, Chih-Chun Lin, Liana S Rosenthal, et al.
Journal of Proteome Research|August 13, 2021
Evaluation of the Sensitivity and Reproducibility of Targeted Proteomic Analysis Using Data-Independent Acquisition for Serum and Cerebrospinal Fluid ProteinsKyung-Cho Cho, Sungtaek Oh, Yuefan Wang, et al.
Parkinsonism & Related Disorders|April 17, 2026
The relationship between level of education and disease onset and progression in spinocerebellar ataxia types 1, 2, 3, and 6Collin J Anderson, Daria Nesterovich Anderson, Ashley Kucharski, et al.
Clinical Proteomics|May 12, 2020
Development of a novel method for the quantification of tyrosine 39 phosphorylated α- and β-synuclein in human cerebrospinal fluidChan Hyun Na, Gajanan Sathe, Liana S Rosenthal, et al.
Pageof 9